Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
A prospective study of androgen levels, hormone related genes and risk of rheumatoid arthritis
Arthritis Research & Therapy, 06/29/09
Karlson EW et al. – Study demonstrates that the steroid hormone levels measured at a single time point prior to rheumatoid arthritis (RA) onset were not associated with RA risk. These findings do not suggest that androgens or the androgen receptor (AR), estrogen receptor 2 (ESR2), aromatase (CYP19) and progesterone receptor (PGR) genes are important to RA risk in women.
Methods- Aim was to determine the associations between plasma steroid hormones measured prior to RA onset and polymorphisms in the AR, ESR2, CYP19 and PGR and RA risk
- AR, ESR2, CYP19, PGR SNPs were genotyped and the AR CAG repeat in RA case-control studies nested within the Nurses' Health Study (NHS), NHS II and the Women's Health Study
- All controls were matched on cohort, age, Caucasian race, menopausal status, and postmenopausal hormone use
- Plasma dehydroepiandrosterone-sulfate (DHEAS), testosterone, and sex hormone binding globulin (SHBG) were measured in 132 pre-RA samples and 396 matched controls in NHS cohorts
- Mean age of RA diagnosis was 55 yrs in both cohorts; 58% of cases were RF positive at diagnosis
- No association between plasma DHEAS, total testosterone, or calculated free testosterone and risk of future RA
- No association between individual variants or haplotypes in any of the genes and RA or seropositive RA
- No association for the AR CAG repeat
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


